2 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Withdrawn 2 |
Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases LCAR-AIO T cells - Relapsed/Refractory Autoimmune Diseases | Early Phase 1 | Withdrawn | Nanjing Legend Biotech Co. | 2025-06-17 | 2025-07-08 | |
| A Study of RD06-04 in Patients With Active Autoimmune Diseases RD06-04 cell infusion - SLE, Sclerosis | Early Phase 1 | Withdrawn | Nanjing Bioheng Biotech Co., Ltd. | 2024-08-31 | 2026-02-03 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Autoimmune Diseases (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Neuromyelitis Optica (1) · Recurrence (1) · Scleroderma, Systemic (1) · Sclerosis (1)
Cardiovascular Diseases (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Systemic Vasculitis (2) · Vascular Diseases (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Connective Tissue Diseases (1) · Cranial Nerve Diseases (1)
Nanjing Bioheng Biotech Co., Ltd. (1) · Nanjing Legend Biotech Co. (1)
China (2)